 |
Verna Porter, MD
Neurology
Female
English
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
A55356
(310) 319-5098
(310) 319-4552
vporter@mednet.ucla.edu
1801 Wilshire Blvd
Santa Monica, CA 90403
Neurology, UCLA School of Medicine, 1998 - 2000
Neurology, UCLA School of Medicine, 1995 - 1998
Internal Medicine, UCLA School of Medicine, 1994 - 1995
MD, UCLA School of Medicine, 1994
| Alzheimer's Disease, Ataxia, Cognitive, Concussion, Electroencephalogram (EEG), Facial Pain, General Neurology, Geriatric Behavior, Guillain Barre Syndrome, Head Trauma, Headache, Hydrocephalus, Memory Disorders, Movement Disorders, Multiple Sclerosis, Neuro Behavior, Neuro Otology, Neuropathy, Normal Brain Function, Parkinson's Disease, Peripheral Nerve, Sleep Disorders, Spine, Stroke |
Director, UCLA-Santa Monica Neurological Associates
Physician, Neurology, General Neurology Program
UCLA Headlines (UCLA's Office of Media Relations)
Tuesday, Dec. 13, 2005:
In the News: In relation to: Lu PH, Masterman DA, Mulnard R, Cotman C, Miller B, Yaffe K, Reback E, Porter V, Swerdloff R, Cummings JL. Effects of testosterone on cognition and mood of male patients with mild Alzheimer’s disease and healthy elderly men. Archives of Neurology. 2006 Feb; 63(2):177-85. Epub 2005 Dec 12.
ALZHEIMER'S: Research into testosterone therapy for men with Alzheimer's disease led by Po Lu, assistant clinical professor of neurology at the UCLA Alzheimer Disease Center, received coverage today from BBC News,
Asian News International (India), Ivanhoe Newswire and DeHavilland Information Services (U.K.); and was featured Monday by Health Day News, United Press International, WebMD, CNN Radio and NBC News Channel. Web coverage of the news release and wire reports included WebIndia123.com, MonstersAndCritics.com, ScienceDaily.com, NewKerala.com (India), HealthCentral.com, AJC.com, Statesman.com and Innovations-Report.com (Germany).
- Selected to be listed in the 2010 Southern California Super Doctors, Los Angeles Magazine (features top five percent of doctors in Los Angeles and Orange counties) January, 2010 Edition
- Selected for inclusion in the 2010 Los Angeles Magazine, Top Doctors January, 2010 Edition
- Selected for inclusion in Marquis Who’s Who in America 2009 & 2010 Editions
- Selected for inclusion in Guide to America’s Top Physicians by the Consumers' Research Council of America (Washington, D.C. based research organization that provides consumers' information guides for professional services throughout America). 2004-2005, 2005-2006, 2006-2007, 2007-2008, 2009-2010 editions
1. Effros RB, Boucher N, Porter VR, Zhu X, Spaulding, C, Walford RL, Kronenberg M, Cohen D, Schachter F. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol. 1994 Nov-Dec; 29(6): 601-9.
2. MacKenzie-Graham AJ, Pribyl TM, Kim S, Porter VR, Campagnoni AT, Voskuhl RR. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis. J Immunol. 1997 Nov 1; 159(9): 4602-10.
3. Porter VR, Greendale G, Schocken M, Zhu X, Effros RB. Immune effects of hormone replacement therapy in post-menopausal women. Exp Gerontol. 2001 Feb; 36(2): 311-26.
4. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, Cummings JL, Effros RB. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging. 2003 Jan-Feb;24(1):77-84.
5. Porter VR, Buxton WG, Fairbanks LA, Strickland T, O'Connor SM, Rosenberg-Thompson S, Cummings JL. Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J Neuropsychiatry Clin Neurosci. 2003 Spring; 15(2): 180-6.
6. Mega MS, Dinov ID, Porter V, Chow G, Reback E, Davoodi P, O'Connor SM, Carter MF, Felix J, Amezcua H, Cummings JL. Metabolic Patterns Associated with the Clinical Response to Galantamine Therapy: An FDG-PET Study. Arch Neurol. 2005 Vol 62, 721-728.
7. Lu PH, Masterman DA, Mulnard R, Cotman C, Miller B, Yaffe K, Reback E, Porter V, Swerdloff R, Cummings JL. Effects of testosterone on cognition and mood of male patients with mild Alzheimer’s disease and healthy elderly men. Archives of Neurology. 2006 Feb; 63(2):177-85. Epub 2005 Dec 12.
8. The IMS II Trial Investigators, Porter V. The International Management of Stroke (IMS) II Study. Stroke. 2007. 38:2127-35. (Porter, V as a clinical investigator)
9. Rahiman A, Saver JL, Porter V, Buxton W, McNair N, Razinia T, Ovbiagele B. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. J Stroke Cerebrovasc Dis. 2008 Jan-Feb;17(1):5-8.
10. CLEAR Stroke Trial Investigators, Porter VR. The Combined Approach to Lysis Using Eptifibatide and rt-PA in Acute Ischemic Stroke: The CLEAR Stroke Trial. Stroke. 2008 39:3268-76. (Porter VR as a clinical investigator).
11. Avagyan H., Goldenson B., Masoumi A., Porter V., Wiedau-Pazos M., Sayre J., Ong R, Tse E, Koo P, Bae S, Mahanian M, Micic M, Liu P, Rosenthal M., Fiala M. Immune blood biomarkers of Alzheimer disease patients. Journal of Neuroimmunology, 210 (2009), 67-72.
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.
Find out how to refer a patient
